Page 1 of 6 · 112 results
|
Symbol
|
Sector
|
Firm
|
Action
|
Grade
|
Target
|
Mkt Cap ▼
|
Base
|
Gap%
|
D1%
|
D2%
|
D3%
|
D4%
|
D5%
|
|
AAPL
|
Technology |
Piper Sandler |
Maintains
|
Overweight
→
Overweight
|
—
|
$4.5T
|
$116.87
|
+0.5%
|
-1.0%
|
-0.6%
|
+0.0%
|
+1.3%
|
-4.6%
|
|
TSLA
|
Consumer Cyclical |
Canaccord Genuity |
Maintains
|
Hold
→
Hold
|
—
|
$1.4T
|
$140.88
|
+4.6%
|
+0.7%
|
-1.2%
|
-0.1%
|
+1.0%
|
-4.4%
|
|
TSLA
|
Consumer Cyclical |
BairdA |
Upgrade
|
Neutral
→
Outperform
|
—
|
$1.4T
|
$140.88
|
+4.6%
|
+0.7%
|
-1.2%
|
-0.1%
|
+1.0%
|
-4.4%
|
|
TSLA
|
Consumer Cyclical |
Oppenheimer |
Maintains
|
Outperform
→
Outperform
|
—
|
$1.4T
|
$140.88
|
+4.6%
|
+0.7%
|
-1.2%
|
-0.1%
|
+1.0%
|
-4.4%
|
|
TSLA
|
Consumer Cyclical |
JMP SecuritiesB |
Upgrade
|
Market Perform
→
Market Outperform
|
—
|
$1.4T
|
$140.88
|
+4.6%
|
+0.7%
|
-1.2%
|
-0.1%
|
+1.0%
|
-4.4%
|
|
LRCX
|
Technology |
KeyBanc |
Maintains
|
Overweight
→
Overweight
|
—
|
$352.7B
|
$36.66
|
-1.7%
|
-2.3%
|
-1.1%
|
-1.8%
|
-1.1%
|
-1.4%
|
|
LRCX
|
Technology |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$352.7B
|
$36.66
|
-1.7%
|
-2.3%
|
-1.1%
|
-1.8%
|
-1.1%
|
-1.4%
|
|
LRCX
|
Technology |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$352.7B
|
$36.66
|
-1.7%
|
-2.3%
|
-1.1%
|
-1.8%
|
-1.1%
|
-1.4%
|
|
TMO
|
Healthcare |
Stifel |
Maintains
|
Buy
→
Buy
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
TMO
|
Healthcare |
Baird |
Maintains
|
Outperform
→
Outperform
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
TMO
|
Healthcare |
Credit Suisse |
Maintains
|
Neutral
→
Neutral
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
TMO
|
Healthcare |
SVB Leerink |
Maintains
|
Outperform
→
Outperform
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
TMO
|
Healthcare |
BTIG |
Maintains
|
Buy
→
Buy
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
TMO
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$168.8B
|
$468.76
|
+0.6%
|
+2.8%
|
-0.4%
|
+0.5%
|
+1.4%
|
-2.6%
|
|
APH
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$157.2B
|
$28.74
|
+0.1%
|
+3.1%
|
+1.0%
|
-2.8%
|
-1.2%
|
-3.1%
|
|
ABT
|
Healthcare |
Raymond James |
Maintains
|
Outperform
→
Outperform
|
—
|
$154.4B
|
$105.93
|
+0.5%
|
+3.4%
|
-1.5%
|
+1.1%
|
-0.4%
|
-2.0%
|
|
ABT
|
Healthcare |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$154.4B
|
$105.93
|
+0.5%
|
+3.4%
|
-1.5%
|
+1.1%
|
-0.4%
|
-2.0%
|
|
ABT
|
Healthcare |
UBS |
Maintains
|
Buy
→
Buy
|
—
|
$154.4B
|
$105.93
|
+0.5%
|
+3.4%
|
-1.5%
|
+1.1%
|
-0.4%
|
-2.0%
|
|
ABT
|
Healthcare |
Morgan Stanley |
Maintains
|
Overweight
→
Overweight
|
—
|
$154.4B
|
$105.93
|
+0.5%
|
+3.4%
|
-1.5%
|
+1.1%
|
-0.4%
|
-2.0%
|
|
ABT
|
Healthcare |
Credit Suisse |
Maintains
|
Outperform
→
Outperform
|
—
|
$154.4B
|
$105.93
|
+0.5%
|
+3.4%
|
-1.5%
|
+1.1%
|
-0.4%
|
-2.0%
|
Page 1 of 6 · 112 results